PRASUGREL TEVA 10 MG

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

اشتر الآن

العنصر النشط:

PRASUGREL AS HYDROBROMIDE

متاح من:

ABIC MARKETING LTD, ISRAEL

ATC رمز:

B01AC22

الشكل الصيدلاني:

FILM COATED TABLETS

تركيب:

PRASUGREL AS HYDROBROMIDE 10 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

المجال العلاجي:

PRASUGREL

الخصائص العلاجية:

Prasugrel Teva, co-administered with acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in patients with acute coronary syndrome ( i.e. unstable angina, non-ST segment elevation myocardial infarction [UA/NSTEMI] or ST segment elevation myocardial infarction [STEMI] undergoing primary or delayed percutaneous coronary intervention (PCI). The increased efficacy should be balanced with the increased risk in patients with bleeding tendencyin those who had TIA/CVA in the past and in those above the age of 75 or weight below 60 kg.

تاريخ الترخيص:

2021-01-03

نشرة المعلومات

                                PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) – 1986
THE MEDICINE IS DISPENSED WITH A DOCTOR'S PRESCRIPTION ONLY
PRASUGREL TEVA 5 MG
FILM-COATED TABLETS
COMPOSITION
Each film-coated tablet contains:
Prasugrel (as hydrobromide) 5 mg
PRASUGREL TEVA 10 MG
FILM-COATED TABLETS
COMPOSITION
Each film-coated tablet contains:
Prasugrel (as hydrobromide) 10 mg
For information regarding inactive ingredients and allergens, see the
section titled “Important information about some of the ingredients
of
the medicine” and section 6 - “Additional information”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This
leaflet contains concise information about the medicine. If you have
additional questions, refer to the doctor or the pharmacist.
This medicine has been prescribed for your treatment. Do not pass
it on to others. It may harm them even if it seems to you that their
medical condition is similar.
PRASUGREL TEVA is not intended for children and adolescents under the
age of 18, since no information is available regarding the efficacy
and
safety of this medicine in this age group.
1. WHAT IS THE MEDICINE INTENDED FOR?
PRASUGREL TEVA in combination with acetylsalicylic acid is intended
for
prevention of atherothrombotic events in patients with acute coronary
syndrome (unstable angina pectoris, acute myocardial infarction) who
are undergoing primary or planned catheterization with or without a
stent.
THERAPEUTIC CLASS: platelet aggregation inhibitors.
2. BEFORE USING THE MEDICINE
DO NOT USE THIS MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient or to any of
the additional components the medicine contains (see section
6). An allergic reaction may occur as a rash, itch, swelling of the
face and lips or shortness of breath. If you experience any of
these effects, inform your doctor immediately
•
You have active bleeding (such as bleeding from an ulcer in your
digestive system)
•
You have previously had a stroke or a transient ischemic attack
(TIA)
•
                                
                                اقرأ الوثيقة كاملة
                                
                            

خصائص المنتج

                                [לוגו מדינת ישראל] [http://www.gov.il/]
[http://www.gov.il/] [לוגו משרד הבריאות] [לוגו משרד
הבריאות] [*5400]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
הציבור הרחב עסקים ומוסדות עובדים
בבריאות חפש מידע
תפריט	*
[סגירה]
סגור	*
דף הבית [http://www.health.gov.il/]	*
אודות	*
אודות המשרד
[http://www.health.gov.il/About/Pages/about_us.aspx]	*
תוכנית עבודה
[http://www.health.gov.il/About/Pages/Agenda.aspx]	*
תקציב המשרד
[http://www.health.gov.il/About/Pages/budget.aspx]	*
תרשים מבנה ארגוני
[http://www.health.gov.il/About/Pages/OrganizationalStructureDiagram.aspx]	*
בעלי תפקידים
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx]	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx?tab=3]	*
אמנת שירות
[http://www.health.gov.il/About/sla/Pages/default.aspx]	*
אותות ופרסים
[http://www.health.gov.il/About/Awards/Pages/mifal.aspx]	*
פרוייקטים תשתיתיים
[http://www.health.gov.il/About/projects/shared_medical_info/Pages/default.aspx]	*
דרושים
[http://www.health.gov.il/About/Careers/Pages/default.aspx]	*
מנכ"לי משרד הבריאות לדורותיהם
[http://www.health.gov.il/About/Pages/GeneralManegerHistory.aspx]	*
יחידות המשרד	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/UnitsOffice/LB/Pages/default.aspx]	*
וועדות ומועצות
[http://www.health.gov.il/Services/Committee/Pages/CommitteeList.aspx]	*
נושאים	*
בריאות הנפש
[http://www.health.gov.il/Subjects/mental_health/Pages/default.aspx]	*
בריאות הסביבה
[http://www.health.gov.il/Subjects/Environmental_Health/
                                
                                اقرأ الوثيقة كاملة
                                
                            

مستندات بلغات أخرى

نشرة المعلومات نشرة المعلومات العربية 20-10-2021
نشرة المعلومات نشرة المعلومات العبرية 20-10-2021

تنبيهات البحث المتعلقة بهذا المنتج

عرض محفوظات المستندات